Paul R Hosking

发表

Local Disease Control in Ocular Adnexal Lymphoproliferative Disorders: Comparative Outcomes of MALT Versus Non‐MALT Histologies

B. Erickson, P. Hari, M. Siker, 2017, Clinical lymphoma, myeloma & leukemia.

Early Fluorescence in situ Hybridization Assessment during Acute Myeloid Leukemia Induction Chemotherapy

P. Hari, Jess F. Peterson, R. Brazauskas, 2018, Acta Haematologica.

Methotrexate-induced CD30+ T-cell lymphoproliferative disorder of the oral cavity

S. Hwang, S. Schieke, Paul R Hosking, 2016, JAAD case reports.

Carcinocythemia: A rare entity becoming more common? A 3‐year, single institution series of seven cases and literature review

A. Harrington, S. Kroft, H. Olteanu, 2018, International journal of laboratory hematology.

Evaluation of CD43 expression in non-hematopoietic malignancies.

A. Mackinnon, A. Harrington, S. Kroft, 2017, Annals of diagnostic pathology.

CD30 Expression in Monomorphic Posttransplant Lymphoproliferative Disorder, Diffuse Large B-Cell Lymphoma Correlates With Greater Regulatory T-Cell Infiltration

A. Harrington, S. Kroft, H. Olteanu, 2017, American journal of clinical pathology.

Immunophenotypes of Chronic Myelomonocytic Leukemia (CMML) Subtypes by Flow Cytometry: A Comparison of CMML-1 vs CMML-2, Myeloproliferative vs Dysplastic, De Novo vs Therapy-Related, and CMML-Specific Cytogenetic Risk Subtypes.

A. Harrington, S. Kroft, H. Olteanu, 2016, American journal of clinical pathology.

Pure Erythroid Leukemia and Erythroblastic Sarcoma Evolving From Chronic Myeloid Neoplasms.

M. Ewalt, A. Harrington, S. Kroft, 2016, American journal of clinical pathology.

Immunophenotypes of Chronic Myelomonocytic Leukemia (CMML) Subtypes by Flow Cytometry: A Comparison of CMML-1 vs CMML-2, Myeloproliferative vs Dysplastic, De Novo vs Therapy-Related, and CMML-Specific Cytogenetic Risk Subtypes.

A. Harrington, S. Kroft, H. Olteanu, 2016, American journal of clinical pathology.